Skip to main content
Clinical Trials/JPRN-jRCT1092220058
JPRN-jRCT1092220058
Not yet recruiting
未知

on-invasive hemodynamic assessment of pregnant patients using esCCO (estimated continuous cardiac output) - esCCO in pregnant patients

Motoshi Tanaka0 sites20 target enrollmentMarch 16, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
healthy pregnant women scheduled for cesarean delivery
Sponsor
Motoshi Tanaka
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Motoshi Tanaka

Eligibility Criteria

Inclusion Criteria

  • pregnant patients scheduled for elective cesarean section

Exclusion Criteria

  • pregant patients with complications

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Non-invasive Haemodynamic Monitoring in PregnancyPregnancy RelatedCardiac Output, HighHaemodynamic Instability
NCT03046784Hospital Nord55
Recruiting
Not Applicable
Bio-impedance monitoring in patients hospitalized with acute decompensated heart failureHeart Failure, Acute Heart Failure
NL-OMON23218Philips Research Eindhoven20
Unknown
Not Applicable
Body Impedance Method in Patients Undergoing Urgent and Elective Cesarian SectionCesarean Section Complications
NCT04230525Gaziosmanpasa Research and Education Hospital95
Active, not recruiting
Not Applicable
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10
Completed
Not Applicable
Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard TherapyPregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia)Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe)Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia)
NCT01248169University of Mississippi Medical Center30